Mutation-Specific Potency and Efficacy of Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Potentiators-Reference-Cited by-同舟云学术

Mutation-Specific Potency and Efficacy of Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Potentiators

Published:2009-06-02 Issue:3 Volume:330 Page:783-791
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Caputo Antonella,Hinzpeter Alexandre,Caci Emanuela,Pedemonte Nicoletta,Arous Nicole,Di Duca Marco,Zegarra-Moran Olga,Fanen Pascale,Galietta Luis J. V.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference40 articles.

1. G551D and G1349D, Two CF-associated Mutations in the Signature Sequences of CFTR, Exhibit Distinct Gating Defects

2. Properties of CFTR activated by the xanthine derivative X-33 in human airway Calu-3 cells

3. Evidence for direct CFTR inhibition by CFTRinh-172 based on Arg347 mutagenesis

4. Phloxine B Interacts with the Cystic Fibrosis Transmembrane Conductance Regulator at Multiple Sites to Modulate Channel Activity

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recommended Tool Compounds for Modifying the Cystic Fibrosis Transmembrane Conductance Regulator Channel Variants;ACS Pharmacology & Translational Science;2024-03-14

2. Laboratory Tools to Predict CFTR Modulator Therapy Effectiveness and to Monitor Disease Severity in Cystic Fibrosis;Journal of Personalized Medicine;2024-01-13

3. Rescue of Rare CFTR Trafficking Mutants Highlights a Structural Location-Dependent Pattern for Correction;International Journal of Molecular Sciences;2023-02-06

4. Advances in Preclinical In Vitro Models for the Translation of Precision Medicine for Cystic Fibrosis;Journal of Personalized Medicine;2022-08-16

5. Theratyping of the Rare CFTR Variants E193K and R334W in Rectal Organoid-Derived Epithelial Monolayers;Journal of Personalized Medicine;2022-04-14